Manufacturing

Articles

Sanofi will perform the fill/finish of up to 200 million doses of Moderna’s COVID-19 vaccine at its Ridgefield, NJ, facility starting in September 2021. 

Sanofi to Manufacture up to 200 Million Doses of Moderna’s COVID-19 Vaccine

Under the terms of the expanded agreement, Catalent will provide Moderna with a new high-speed vial filling line until June 2023 along with inspection, labeling, cartoning, and final packaging for potential pipeline programs.

Catalent Expands COVID-19 Vaccine Fill/Finish Collaboration with Moderna

The expanded agreement will include aseptic fill/finish services at its San Diego, CA facility.

Aji Bio-Pharma Expands Agreement with AstraZeneca to Include Drug Product Manufacturing

Manufacturing of the vaccine will take place at Baxter’s fill/finish sterile manufacturing facilities located in Bloomington, IN.

Baxter to Provide Fill/Finish and Packaging Services for Moderna’s COVID-19 Vaccine

The guidance document provides recommendations for reporting and implementing changes to container closure system components consisting of glass vials and stoppers for sterile drug products.

FDA Publishes Guidance on Changes to COVID-19 Container Closure Systems

Feliza Mirasol is the science editor for 

While manufacturing increases have been implemented for vials and syringes, meeting future market needs remains unpredictable.

Increases in Manufacturing Capacity Target Vial and Syringe Shortages

CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.

Meeting Fill/Finish Challenges for COVID-19 Vaccines

Cytiva acquired Vanrx Pharmasystems, a Canadian manufacturer of robotic aseptic filling equipment.

Cytiva Acquires Vanrx Pharmasystems

Clinical material for a Theratechnologies product in development will be produced at PPS’ manufacturing facility in Lexington, KY.

Piramal Pharma Solutions to Provide Sterile Fill/Finish Support to Theratechnologies

The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States. 

Manufacturing, Fill/Finish